Review of the top 5 cardiology studies of 2023-24.
作者信息
Barry Arden R, Boswell Rosaleen, Babadagli Hazal E, Chen June W, Cowley Emily, Eberhardt Theresa E, May Taryn A
机构信息
Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC.
Jim Pattison Outpatient Care and Surgery Centre, Lower Mainland Pharmacy Services, Surrey, BC.
出版信息
Can Pharm J (Ott). 2025 Jun 11:17151635251339445. doi: 10.1177/17151635251339445.
Abstract
摘要
相似文献
1
Review of the top 5 cardiology studies of 2023-24.
Can Pharm J (Ott). 2025 Jun 11:17151635251339445. doi: 10.1177/17151635251339445.
2
Clinical outcome measures in the assessment of impact of pharmacists in cardiology ambulatory care: A systematic review.
Res Social Adm Pharm. 2023 Mar;19(3):432-444. doi: 10.1016/j.sapharm.2022.09.018. Epub 2022 Oct 11.
3
Primer on statistical interpretation or methods report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review.
Circ Cardiovasc Qual Outcomes. 2008 Sep;1(1):62-7. doi: 10.1161/CIRCOUTCOMES.108.790634.
4
American College of Cardiology and American Heart Association blood pressure categories-a systematic review of the relationship with adverse pregnancy outcomes in the first half of pregnancy.
Am J Obstet Gynecol. 2023 Apr;228(4):418-429.e34. doi: 10.1016/j.ajog.2022.10.004. Epub 2022 Oct 12.
5
Knowledge discovery in cardiology: A systematic literature review.
Int J Med Inform. 2017 Jan;97:12-32. doi: 10.1016/j.ijmedinf.2016.09.005. Epub 2016 Sep 14.
6
Randomized Controlled Trials in Pediatric Cardiology: A Power Struggle?
Pediatr Cardiol. 2023 Feb;44(2):306-311. doi: 10.1007/s00246-022-03039-z. Epub 2022 Nov 2.
7
Exploring the Role of Advanced Practice Nurses in Cardiology: A Scoping Review.
Int Nurs Rev. 2025 Sep;72(3):e70054. doi: 10.1111/inr.70054.
8
Advances in Clinical Cardiology 2024: A Summary of Key Clinical Trials.
Adv Ther. 2025 May 19. doi: 10.1007/s12325-025-03220-9.
9
Systematic review of current natural language processing methods and applications in cardiology.
Heart. 2022 May 25;108(12):909-916. doi: 10.1136/heartjnl-2021-319769.
10
Surviving the Struggle of COVID-19: Practical Recommendations for Pediatric/Adult Cardiology and Cardiac Surgical Programs in Resource-Limited Settings: a Review.
Braz J Cardiovasc Surg. 2022 Mar 10;37(1):99-109. doi: 10.21470/1678-9741-2021-0477.
本文引用的文献
1
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med. 2025 Jan 30;392(5):427-437. doi: 10.1056/NEJMoa2410027. Epub 2024 Nov 16.
2
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
Lancet. 2024 Jul 20;404(10449):245-255. doi: 10.1016/S0140-6736(24)01028-6. Epub 2024 Jun 27.
3
Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Am J Cardiol. 2024 Jul 1;222:121-130. doi: 10.1016/j.amjcard.2024.04.041. Epub 2024 Apr 26.
4
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
Lancet. 2024 May 11;403(10439):1866-1878. doi: 10.1016/S0140-6736(24)00473-2. Epub 2024 Apr 7.
5
Routine Beta-Blockers in Secondary Prevention - On Injured Reserve.
N Engl J Med. 2024 Apr 18;390(15):1434-1436. doi: 10.1056/NEJMe2402731. Epub 2024 Apr 7.
6
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
N Engl J Med. 2024 Apr 18;390(15):1372-1381. doi: 10.1056/NEJMoa2401479. Epub 2024 Apr 7.
7
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
N Engl J Med. 2024 Apr 18;390(15):1394-1407. doi: 10.1056/NEJMoa2313917. Epub 2024 Apr 6.
8
Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy.
Can J Cardiol. 2024 Feb;40(2):160-181. doi: 10.1016/j.cjca.2023.10.013. Epub 2023 Oct 29.
9
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11.
10
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
Circulation. 2024 Jan 23;149(4):279-289. doi: 10.1161/CIRCULATIONAHA.123.066485. Epub 2023 Aug 27.
Zotero 插件